Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.63 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.56 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.55 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.55 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.55 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | CA4 | P22748 | 1/20 | 0.53 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.53 |
| ▸ | TFEB | P19484 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 3/20 | 0.52 |
| ▸ | RAB9A | P51151 | 3/20 | 0.52 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1711265 | 1.00 | HTT (0.63) | HTTGAASMN1; SMN2KDM4EPTGER1 | |
| SCHEMBL4715093 | 1.00 | HTT (0.63) | HTTGAASMN1; SMN2KDM4EPTGER1 | |
| SCHEMBL13036867 | 0.88 | NFE2L2 (0.69) | HTTKDM4EMEN1KMT2ANFKB1 | |
| SCHEMBL20110943 | 0.88 | KDM4E (0.72) | HTTKDM4EMEN1KMT2ANFE2L2 | |
| SCHEMBL1603612 | 0.87 | MEN1 (0.60) | SMN1; SMN2KDM4EMEN1KMT2ANFKB1 | |
| SCHEMBL16498326 | 0.85 | MAPT (0.72) | HTTSMN1; SMN2KDM4EMEN1KMT2A | |
| SCHEMBL16498329 | 0.85 | MAPT (0.72) | HTTSMN1; SMN2KDM4EMEN1KMT2A | |
| SCHEMBL17305571 | 0.85 | KDM4E (0.54) | HTTGAAKDM4EMEN1KMT2A | |
| SCHEMBL4712845 | 0.85 | KDM4E (0.54) | HTTGAASMN1; SMN2KDM4EMEN1 | |
| SCHEMBL18121457 | 0.85 | KDM4E (0.54) | HTTGAAKDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0153538-B1 | DERIVATIVES OF MELILOTIC ACID, AND MEDICAMENTS CONTAINING THEM | Laboratoire Marcel Richard Société anonyme dite (FR) | 1986-11-26 | — | — | EP | claimed |
| JP-63039847-A | — | — | None | — | — | JP | disclosed |
| CN-116003710-B | Polyacrylic polymer modified substrate, preparation method thereof and application thereof in preparation of biochip | 中国海洋大学 | 2025-04-08 | — | — | CN | disclosed |
| CN-119193555-A | Ferulic acid decarboxylase high-activity mutant and application thereof | 大连理工大学 | 2024-12-27 | — | — | CN | disclosed |
| CN-118086266-B | Ferulic acid decarboxylase high-activity combined mutant and application thereof | 大连理工大学 | 2024-10-25 | — | — | CN | disclosed |
| CN-118086266-A | Ferulic acid decarboxylase high-activity combined mutant and application thereof | 大连理工大学 | 2024-05-28 | — | — | CN | disclosed |
| US-11873354-B2 | Photobase generator, compound, photoreactive composition, and reaction product | TOKYO UNIVERSITY OF SCIENCE FOUNDATION (JP) | 2024-01-16 | — | — | US | disclosed |
| CN-116003710-A | Polyacrylic polymer modified substrate, preparation method thereof and application thereof in preparation of biochip | 中国海洋大学 | 2023-04-25 | — | — | CN | disclosed |
| US-20210214374-A1 | COMPOUNDS AND COMPOSITIONS FOR OCULAR DELIVERY | Graybug Vision, Inc. (US) | 2021-07-15 | — | — | US | disclosed |
| US-20210214374-A1 | COMPOUNDS AND COMPOSITIONS FOR OCULAR DELIVERY | Graybug Vision, Inc. (US) | 2021-07-15 | — | — | US | disclosed |
| EP-1091958-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2001-04-18 | — | — | EP | disclosed |
| EP-1049682-A1 | OXAZOLIDINONE COMBINATORIAL LIBRARIES, COMPOSITIONS AND METHODS OF PREPARATION | Versicor, Inc. (US) | 2000-11-08 | — | — | EP | disclosed |
| WO-2000001692-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2000-01-13 | — | — | WO | disclosed |
| WO-1999037630-A1 | OXAZOLIDINONE COMBINATORIAL LIBRARIES, COMPOSITIONS AND METHODS OF PREPARATION | VERSICOR, INC. (US) | 1999-07-29 | — | — | WO | disclosed |
| US-5599478-A | Compensator for a liquid crystal display | NIPPON OIL COMPANY, LIMITED (JP) | 1997-02-04 | — | — | US | disclosed |
| EP-0702260-A1 | Compensator for a liquid crystal display | NIPPON OIL CO. LTD. (JP) | 1996-03-20 | — | — | EP | disclosed |
| EP-0656927-A1 | METALLO ORGANO LIQUID CRYSTALS IN A POLYMER MATRIX | Sniaricerche S.C.P.A. (IT) | 1995-06-14 | — | — | EP | disclosed |
| EP-0343714-B1 | Phenylglycidate stereoisomers, conversion products thereof with e.g. 2-nitrothiophenol and preparation of diltiazem | DSM NV (NL) | 1994-11-02 | — | — | EP | disclosed |
| EP-0343714-A1 | Phenylglycidate stereoisomers, conversion products thereof with e.g. 2-nitrothiophenol and preparation of diltiazem | DSM N.V. (NL) | 1989-11-29 | — | — | EP | disclosed |
| JP-S6339847-A | P-HYDROXYCINNAMAMIDE DERIVATIVE AND MELANIN SUPPRESSIVE AGENT CONTAINING SAME | KAO CORP | 1988-02-20 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11873354-B2 | Photobase generator, compound, photoreactive composition, and reaction product | GNB1, GNAQ, GNG2 | HTT 4751/4885GAA 1661/4885SMN1; SMN2 4542/4885 |
| US-20210214374-A1 | COMPOUNDS AND COMPOSITIONS FOR OCULAR DELIVERY | KDR, RB1, PDE6C | HTT 1142/4885GAA 892/4885SMN1; SMN2 700/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.